AngioDynamics to Report Fiscal 2023 Third Quarter Financial Results on March 30, 2023

Rhea-AI Summary

AngioDynamics, Inc. (NASDAQ: ANGO) will report its financial results for Q3 of fiscal year 2023 on March 30, 2023, before the market opens. A conference call is scheduled for 8:00 a.m. ET that same day to discuss the results. Interested participants can call 1-877-407-0784 (domestic) or +1-201-689-8560 (international) using passcode 13737051. The call will also be available via webcast on the AngioDynamics website, with a replay accessible beginning at 11:00 a.m. ET on the same day until April 6, 2023.

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today announced that it will report financial results for the third quarter of fiscal year 2023 before the market open on Thursday, March 30, 2023. The Company’s management will host a conference call at 8:00 a.m. ET the same day to discuss the results.

To participate in the conference call, dial 1-877-407-0784 (domestic) or +1- 201-689-8560 (international) and refer to the passcode 13737051.

This conference call will also be webcast and can be accessed from the “Investors” section of the AngioDynamics website at www.angiodynamics.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

A recording of the call will also be available from 11:00 a.m. ET on Thursday, March 30, 2023, until 11:59 p.m. ET on Thursday, April 6, 2023. To hear this recording, dial 1-844-512-2921 (domestic) or +1-412-317-6671 (international) and enter the passcode 13737051.

About AngioDynamics, Inc.

AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients.

The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230313005747/en/

Investor:



AngioDynamics, Inc.

Stephen Trowbridge, Executive Vice President & CFO

(518) 795-1408

Source: AngioDynamics, Inc.

FAQ

When will AngioDynamics report its Q3 fiscal 2023 financial results?

AngioDynamics will report its Q3 fiscal 2023 financial results on March 30, 2023, before the market opens.

What time is the AngioDynamics conference call to discuss Q3 results?

The conference call to discuss AngioDynamics' Q3 results is scheduled for 8:00 a.m. ET on March 30, 2023.

How can I access the AngioDynamics conference call?

You can access the AngioDynamics conference call by dialing 1-877-407-0784 (domestic) or +1-201-689-8560 (international) and using passcode 13737051.

Is there a webcast available for the AngioDynamics Q3 results call?

Yes, the conference call will be available via webcast on the AngioDynamics website under the 'Investors' section.

When will the replay of the AngioDynamics conference call be available?

The replay of the AngioDynamics conference call will be available starting at 11:00 a.m. ET on March 30, 2023, until 11:59 p.m. ET on April 6, 2023.